Aspire Biopharma Holdings (ASBP) Research & Development (2024 - 2026)
Aspire Biopharma Holdings' (ASBP) quarterly Research & Development came in at $334739.0 in Q1 2026, up 27.23% year-on-year from $263093.0 in Q1 2025, and up 259.2% on a QoQ basis from $93190.0 in Q4 2025.
Aspire Biopharma Holdings (ASBP) Research & Development (2024 - 2026) Analysis & Trends
Aspire Biopharma Holdings (ASBP) has 3 years of Research & Development data on file, last reported at $334739.0 in Q1 2026.
- On a quarterly basis, Research & Development rose 27.23% year-over-year to $334739.0 in Q1 2026; TTM through Mar 2026 was $687139.0, a 81.45% increase from a year earlier, with the FY2025 full-year figure at $789829.0, up 526.38% from the prior year.
- Research & Development for Q1 2026 stood at $334739.0, up from $93190.0 in the prior quarter.
- Over the last five years, Research & Development for ASBP reached as high as $334739.0 in Q1 2026 and fell as low as $7000.0 in Q3 2024.
- Historically, Research & Development has averaged $128165.8 across 3 years, with a median of $93190.0 in 2025.
- On a YoY basis, Research & Development climbed as much as 2869.99% in 2025 and fell as far as 5.0% in 2025.
- Year by year, Research & Development stood at $98094.0 in 2024, then fell by 5.0% to $93190.0 in 2025, then soared by 259.2% to $334739.0 in 2026.
- Per Business Quant data, the three most recent Research & Development figures were $334739.0 in Q1 2026, $93190.0 in Q4 2025, and $207899.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 541.22 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -2.31 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.37 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 343.97 Mn |
| 10 | Aspire Biopharma Holdings | 1.21 Mn | -619,284.29 | 5,750.00 | 334,739.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 334,739.00 |
| Dec 31, 2025 | 93,190.00 |
| Sep 30, 2025 | 207,899.00 |
| Jun 30, 2025 | 51,311.00 |
| Mar 31, 2025 | 263,093.00 |
| Dec 31, 2024 | 98,094.00 |
| Sep 30, 2024 | 7,000.00 |
| Jun 30, 2024 | 10,500.00 |
| Mar 31, 2024 | 87,666.00 |